The U.S. Food and Drug Administration (FDA) announced in a press release that they have put together draft guidelines regarding opioid alternatives for chronic pain patients. The goal of this action is to “address the opioid crisis,” and broaden accessibility of “safe and effective non-opioid treatments and to reduce prescription-related opioid misuse.”
The guidance, “Development of Non-Opioid Analgesics for Chronic Pain,” is open for public comment for 60 days. It was designed to offer recommendations for various patient needs, clinical trial development, opioid alternates, and drug development support.
